Literature DB >> 6502728

Glucose-6-phosphate dehydrogenase revisited.

J T O'Connell, A R Henderson.   

Abstract

Hemolytic diseases associated with drugs have been recognized since antiquity. Many of these anemias have been associated with oxidizing agents and deficiencies in the intraerythrocytic enzyme glucose-6-phosphate dehydrogenase. This paper outlines the discovery, prevalence, and variants of this enzyme. Methods of diagnosis of associated anemias are offered.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6502728      PMCID: PMC2609771     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  7 in total

1.  Enzymatic deficiency in primaquine-sensitive erythrocytes.

Authors:  A S ALVING; P E CARSON; C L FLANAGAN; C E ICKES
Journal:  Science       Date:  1956-09-14       Impact factor: 47.728

2.  The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes.

Authors:  E BEUTLER; R J DERN; C L FLANAGAN; A S ALVING
Journal:  J Lab Clin Med       Date:  1955-02

3.  The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals.

Authors:  R J DERN; I M WEINSTEIN; G V LEROY; D W TALMAGE; A S ALVING
Journal:  J Lab Clin Med       Date:  1954-02

4.  Toxicity of primaquine in Negroes.

Authors:  R S HOCKWALD; J ARNOLD; C B CLAYMAN; A S ALVING
Journal:  J Am Med Assoc       Date:  1952-08-23

5.  Hemolysis due to inherited erythrocyte enzyme deficiencies.

Authors:  P E Carson
Journal:  Ann N Y Acad Sci       Date:  1968-07-31       Impact factor: 5.691

Review 6.  Glucose-6-phosphate dehydrogenase deficiency and related disorders of the pentose phosphate pathway.

Authors:  P E Carson; H Frischer
Journal:  Am J Med       Date:  1966-11       Impact factor: 4.965

7.  STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. IX. EFFECT OF PAMAQUINE ON THE BLOOD CELLS OF MAN.

Authors:  D P Earle; F S Bigelow; C G Zubrod; C A Kane
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.